Araştırma Makalesi
BibTex RIS Kaynak Göster

COVİD 19'DA ÖNE ÇIKAN BİYOKİMYASAL PARAMETRELERİN VE D VİTAMİNİNİN DEĞERLENDİRİLMESİ

Yıl 2022, Cilt: 13 Sayı: 4, 444 - 450, 30.12.2022
https://doi.org/10.18663/tjcl.899895

Öz

Amaç: Bu çalışmada hastalığın seyrini tahmin etmek ve yoğun bakım ünitesine yatırılacak hastaları önceden belirlemek için potansiyel koagülasyon ve inflamasyon biyobelirteçlerini ve son dönemde sıkça vurgulanan D vitaminini değerlendirmeyi amaçladık.
Gereç ve Yöntemler: Bu retrospektif vaka-kontrol çalışması, Mart 2020'den Haziran 2020'ye kadar Amasya Sabuncuoğlu Şerefeddin Eğitim ve Araştırma Hastanesi'nde COVİD-19 tanısı alıp tedavi edilen 121 hasta üzerinde yapıldı. COVİD-19 ile ilişkili olabilecek D-dimer, fibrinojen, ferritin ve 25-OH Vitamin D'yi değerlendirdik. Hastalar, sadece polimeraz zincir reaksiyon pozitifliği (PCR +), sadece bilgisayarlı tomografi pozitifliği (CT +) ve hem PCR + hem de CT + olmak üzere üç gruba ayrıldı.
Bulgular: Yaş ortalaması 53 olan 121 hasta incelendi (% 52 erkek). Sadece CT + hastalar diğer hastalardan daha yaşlıydı (p <0.001). D-dimer, ferritin ve fibrinojen seviyeleri tüm hastalar arasında CT + olan grupta oldukça yüksekti (sırasıyla p = 0.001, p = 0.001 ve p <0.001). Hem PCR + hem de CT + olanlar ve diğerleri, CT + olanlar ve diğerleri, PCR + olanlar ve diğerleri karşılaştırıldığında D vitamini düzeyleri arasında anlamlı fark bulunamadı (p = 0.277, p = 0.350, p = 0.397). Bununla beraber tüm gruplarda D vitamini düzeylerinin yetersiz olduğu tespit edildi.
Sonuç: COVİD-19'a koagülopati eşlik edebileceğinden başvuru esnasındaki D-dimer ve fibrinojen seviyeleri öngörü sağlamaktadır. Serum ferritini ise, COVİD-19 hastalarında kötü prognoz için potansiyel risk faktörü göstergesidir.

Kaynakça

  • Referans 1. Berekaa MM. Insights into the COVID-19 pandemic: Origin, pathogenesis, diagnosis, and therapeutic interventions. Frontiers in bioscience (Elite edition). 2021;13:117-39.
  • Referans 2. Danwang C, Endomba FT, Nkeck JR, Wouna DLA, Robert A, Noubiap JJ. A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19). Biomark Res. 2020;8:37.
  • Referans 3. Mardani R, Ahmadi Vasmehjani A, Zali F, Gholami A, Mousavi Nasab SD, Kaghazian H, et al. Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study. Arch Acad Emerg Med. 2020;8(1):e43.
  • Referans 4. Khourssaji M, Chapelle V, Evenepoel A, Belkhir L, Yombi JC, van Dievoet MA, et al. A biological profile for diagnosis and outcome of COVID-19 patients. Clin Chem Lab Med. 2020;58(12):2141-50.
  • Referans 5. Luo HC, You CY, Lu SW, Fu YQ. Characteristics of coagulation alteration in patients with COVID-19. Ann Hematol. 2021;100(1):45-52.
  • Referans 6. Long H, Nie L, Xiang X, Li H, Zhang X, Fu X, et al. D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis. BioMed Research International. 2020;2020:6159720.
  • Referans 7. Ikewaki N, Rao KS, Archibold AD, Iwasaki M, Senthilkumar R, Preethy S, et al. Coagulopathy associated with COVID-19 - Perspectives & Preventive strategies using a biological response modifier Glucan. Thromb J. 2020;18:27.
  • Referans 8. Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J Infect. 2020;80(6):656-65.
  • Referans 9. Kernan KF, Carcillo JA. Hyperferritinemia and inflammation. Int Immunol. 2017;29(9):401-9.
  • Referans 10. Zdrenghea MT, Makrinioti H, Bagacean C, Bush A, Johnston SL, Stanciu LA. Vitamin D modulation of innate immune responses to respiratory viral infections. Rev Med Virol. 2017;27(1).
  • Referans 11. Panagiotou G, Tee SA, Ihsan Y, Athar W, Marchitelli G, Kelly D, et al. Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity. Clin Endocrinol (Oxf). 2020;93(4):508-11.
  • Referans 12. Munshi R, Hussein MH, Toraih EA, Elshazli RM, Jardak C, Sultana N, et al. Vitamin D insufficiency as a potential culprit in critical COVID-19 patients. Journal of medical virology. 2021;93(2):733-40.
  • Referans 13. Merzon E, Tworowski D, Gorohovski A, Vinker S, Golan Cohen A, Green I, et al. Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. The FEBS journal. 2020;287(17):3693-702.
  • Referans 14. Hastie CE, Mackay DF, Ho F, Celis-Morales CA, Katikireddi SV, Niedzwiedz CL, et al. Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabetes Metab Syndr. 2020;14(4):561-5.
  • Referans 15. Laird E, Rhodes J, Kenny RA. Vitamin D and Inflammation: Potential Implications for Severity of Covid-19. Ir Med J. 2020;113(5):81.
  • Referans 16. Hayiroglu MI, Cinar T, Tekkesin AI. Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review. Rev Assoc Med Bras (1992). 2020;66(6):842-8.
  • Referans 17. Perricone C, Bartoloni E, Bursi R, Cafaro G, Guidelli GM, Shoenfeld Y, et al. COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy. Immunologic research. 2020;68(4):213-24.
  • Referans 18. Iba T, Levy JH, Levi M, Thachil J. Coagulopathy in COVID-19. J Thromb Haemost. 2020;18(9):2103-9.
  • Referans 19. Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18(5):1023-6.
  • Referans 20. Doğan E SN. Türkiye’de Batı Karadeniz bölgesindeki çocukların D vitamini düzeyleri. Pamukkale Tıp Dergisi. 2021;14(1):1-10.
  • Referans 21. In: Ross AC, Taylor CL, Yaktine AL, Del Valle HB, editors. Dietary Reference Intakes for Calcium and Vitamin D. The National Academies Collection: Reports funded by National Institutes of Health. Washington (DC)2011.
  • Referans 22. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet. 1998;351(9105):805-6.
  • Referans 23. Priemel M, von Domarus C, Klatte TO, Kessler S, Schlie J, Meier S, et al. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res. 2010;25(2):305-12.
  • Referans 24. Cashman KD, Dowling KG, Skrabakova Z, Gonzalez-Gross M, Valtuena J, De Henauw S, et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr. 2016;103(4):1033-44.
  • Referans 25. Bouillon R, Carmeliet G, Lieben L, Watanabe M, Perino A, Auwerx J, et al. Vitamin D and energy homeostasis: of mice and men. Nat Rev Endocrinol. 2014;10(2):79-87.

EVALUATION OF FEATURED BIOCHEMICAL PARAMETERS AND VITAMIN D IN COVID-19

Yıl 2022, Cilt: 13 Sayı: 4, 444 - 450, 30.12.2022
https://doi.org/10.18663/tjcl.899895

Öz

Aim: We aimed to evaluate potential coagulation and inflammatory biomarkers. The recently discussed vitamin D levels predict the course ef the disease and determine the patients to be admitted to the intensive care unit in advance.
Materials and Methods: This retrospective case-control study was conducted on 121 patients diagnosed and treated with COVID-19 disease, from March 2020 to June 2020 at the Amasya Sabuncuoğlu Şerefeddin Training and Research Hospital, Amasya, Turkey. D-dimer, Fibrinogen, Ferritin, and 25-OH Vitamin D levels that could be associated with COVID-19 infections were evaluated. The patients were divided into three groups: only Polymerase Chain Reaction positivity (PCR+), only Computerized Tomography positivity (CT+) and both PCR+ and CT+ among COVID-19 cases.
Results: 121 patients with at mean age of 53 were investigated (52% male). Only CT+ cases were significantly older than other patients, p<0.001. D-dimer, Ferritin, and Fibrinogen levels were considerably higher in CT+ patients among all subjects, p =0.001, p =0.001, and p<0.001, respectively. There were no apparent differences in vitamin D levels between PCR+ and CT+ and others, CT+ and, PCR+ and others, p=0.277, p=0.350, p=0.397. However, we found that vitamin D levels were deficient in all groups.
Conclusion: Since coagulopathy may accompany COVID-19, D-dimer and fibrinogen levels are predictive during admission. Serum ferritin demonstrates a potential risk factor for poor prognosis in COVID‐19 patients.

Kaynakça

  • Referans 1. Berekaa MM. Insights into the COVID-19 pandemic: Origin, pathogenesis, diagnosis, and therapeutic interventions. Frontiers in bioscience (Elite edition). 2021;13:117-39.
  • Referans 2. Danwang C, Endomba FT, Nkeck JR, Wouna DLA, Robert A, Noubiap JJ. A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19). Biomark Res. 2020;8:37.
  • Referans 3. Mardani R, Ahmadi Vasmehjani A, Zali F, Gholami A, Mousavi Nasab SD, Kaghazian H, et al. Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study. Arch Acad Emerg Med. 2020;8(1):e43.
  • Referans 4. Khourssaji M, Chapelle V, Evenepoel A, Belkhir L, Yombi JC, van Dievoet MA, et al. A biological profile for diagnosis and outcome of COVID-19 patients. Clin Chem Lab Med. 2020;58(12):2141-50.
  • Referans 5. Luo HC, You CY, Lu SW, Fu YQ. Characteristics of coagulation alteration in patients with COVID-19. Ann Hematol. 2021;100(1):45-52.
  • Referans 6. Long H, Nie L, Xiang X, Li H, Zhang X, Fu X, et al. D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis. BioMed Research International. 2020;2020:6159720.
  • Referans 7. Ikewaki N, Rao KS, Archibold AD, Iwasaki M, Senthilkumar R, Preethy S, et al. Coagulopathy associated with COVID-19 - Perspectives & Preventive strategies using a biological response modifier Glucan. Thromb J. 2020;18:27.
  • Referans 8. Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J Infect. 2020;80(6):656-65.
  • Referans 9. Kernan KF, Carcillo JA. Hyperferritinemia and inflammation. Int Immunol. 2017;29(9):401-9.
  • Referans 10. Zdrenghea MT, Makrinioti H, Bagacean C, Bush A, Johnston SL, Stanciu LA. Vitamin D modulation of innate immune responses to respiratory viral infections. Rev Med Virol. 2017;27(1).
  • Referans 11. Panagiotou G, Tee SA, Ihsan Y, Athar W, Marchitelli G, Kelly D, et al. Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity. Clin Endocrinol (Oxf). 2020;93(4):508-11.
  • Referans 12. Munshi R, Hussein MH, Toraih EA, Elshazli RM, Jardak C, Sultana N, et al. Vitamin D insufficiency as a potential culprit in critical COVID-19 patients. Journal of medical virology. 2021;93(2):733-40.
  • Referans 13. Merzon E, Tworowski D, Gorohovski A, Vinker S, Golan Cohen A, Green I, et al. Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. The FEBS journal. 2020;287(17):3693-702.
  • Referans 14. Hastie CE, Mackay DF, Ho F, Celis-Morales CA, Katikireddi SV, Niedzwiedz CL, et al. Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabetes Metab Syndr. 2020;14(4):561-5.
  • Referans 15. Laird E, Rhodes J, Kenny RA. Vitamin D and Inflammation: Potential Implications for Severity of Covid-19. Ir Med J. 2020;113(5):81.
  • Referans 16. Hayiroglu MI, Cinar T, Tekkesin AI. Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review. Rev Assoc Med Bras (1992). 2020;66(6):842-8.
  • Referans 17. Perricone C, Bartoloni E, Bursi R, Cafaro G, Guidelli GM, Shoenfeld Y, et al. COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy. Immunologic research. 2020;68(4):213-24.
  • Referans 18. Iba T, Levy JH, Levi M, Thachil J. Coagulopathy in COVID-19. J Thromb Haemost. 2020;18(9):2103-9.
  • Referans 19. Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18(5):1023-6.
  • Referans 20. Doğan E SN. Türkiye’de Batı Karadeniz bölgesindeki çocukların D vitamini düzeyleri. Pamukkale Tıp Dergisi. 2021;14(1):1-10.
  • Referans 21. In: Ross AC, Taylor CL, Yaktine AL, Del Valle HB, editors. Dietary Reference Intakes for Calcium and Vitamin D. The National Academies Collection: Reports funded by National Institutes of Health. Washington (DC)2011.
  • Referans 22. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet. 1998;351(9105):805-6.
  • Referans 23. Priemel M, von Domarus C, Klatte TO, Kessler S, Schlie J, Meier S, et al. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res. 2010;25(2):305-12.
  • Referans 24. Cashman KD, Dowling KG, Skrabakova Z, Gonzalez-Gross M, Valtuena J, De Henauw S, et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr. 2016;103(4):1033-44.
  • Referans 25. Bouillon R, Carmeliet G, Lieben L, Watanabe M, Perino A, Auwerx J, et al. Vitamin D and energy homeostasis: of mice and men. Nat Rev Endocrinol. 2014;10(2):79-87.
Toplam 25 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Özgün Makale
Yazarlar

Elif Menekşe

Muhammed Emin Düz 0000-0002-1837-6415

Aydın Balcı

Mustafa Durmaz 0000-0001-9241-3803

Yayımlanma Tarihi 30 Aralık 2022
Yayımlandığı Sayı Yıl 2022 Cilt: 13 Sayı: 4

Kaynak Göster

APA Menekşe, E., Emin Düz, M., Balcı, A., Durmaz, M. (2022). EVALUATION OF FEATURED BIOCHEMICAL PARAMETERS AND VITAMIN D IN COVID-19. Turkish Journal of Clinics and Laboratory, 13(4), 444-450. https://doi.org/10.18663/tjcl.899895
AMA Menekşe E, Emin Düz M, Balcı A, Durmaz M. EVALUATION OF FEATURED BIOCHEMICAL PARAMETERS AND VITAMIN D IN COVID-19. TJCL. Aralık 2022;13(4):444-450. doi:10.18663/tjcl.899895
Chicago Menekşe, Elif, Muhammed Emin Düz, Aydın Balcı, ve Mustafa Durmaz. “EVALUATION OF FEATURED BIOCHEMICAL PARAMETERS AND VITAMIN D IN COVID-19”. Turkish Journal of Clinics and Laboratory 13, sy. 4 (Aralık 2022): 444-50. https://doi.org/10.18663/tjcl.899895.
EndNote Menekşe E, Emin Düz M, Balcı A, Durmaz M (01 Aralık 2022) EVALUATION OF FEATURED BIOCHEMICAL PARAMETERS AND VITAMIN D IN COVID-19. Turkish Journal of Clinics and Laboratory 13 4 444–450.
IEEE E. Menekşe, M. Emin Düz, A. Balcı, ve M. Durmaz, “EVALUATION OF FEATURED BIOCHEMICAL PARAMETERS AND VITAMIN D IN COVID-19”, TJCL, c. 13, sy. 4, ss. 444–450, 2022, doi: 10.18663/tjcl.899895.
ISNAD Menekşe, Elif vd. “EVALUATION OF FEATURED BIOCHEMICAL PARAMETERS AND VITAMIN D IN COVID-19”. Turkish Journal of Clinics and Laboratory 13/4 (Aralık 2022), 444-450. https://doi.org/10.18663/tjcl.899895.
JAMA Menekşe E, Emin Düz M, Balcı A, Durmaz M. EVALUATION OF FEATURED BIOCHEMICAL PARAMETERS AND VITAMIN D IN COVID-19. TJCL. 2022;13:444–450.
MLA Menekşe, Elif vd. “EVALUATION OF FEATURED BIOCHEMICAL PARAMETERS AND VITAMIN D IN COVID-19”. Turkish Journal of Clinics and Laboratory, c. 13, sy. 4, 2022, ss. 444-50, doi:10.18663/tjcl.899895.
Vancouver Menekşe E, Emin Düz M, Balcı A, Durmaz M. EVALUATION OF FEATURED BIOCHEMICAL PARAMETERS AND VITAMIN D IN COVID-19. TJCL. 2022;13(4):444-50.


e-ISSN: 2149-8296

The content of this site is intended for health care professionals. All the published articles are distributed under the terms of

Creative Commons Attribution Licence,

which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.